Genetic testing for haemochromatosis
In this Audit
This audit is based on a recent article in Best Tests which focused on the diagnosis and management of hereditary haemochromatosis.
The objective of this audit is to ensure that unnecessary genetic testing for haemochromatosis is identified and minimised.
For further information see: “Identifying and managing hereditary
haemochromatosis in adults”, Best Tests (Apr, 2015).
Hereditary haemochromatosis is a condition characterised by increased iron absorption which leads to elevated iron stores and iron deposition in tissues, particularly the liver,
which can lead to complications such as cirrhosis, fibrosis and hepatocellular carcinoma. Most cases of hereditary haemochromatosis are due to common risk alleles; whether a patient
has these alleles can be assessed by genetic testing. Hereditary haemochromatosis is an autosomal recessive disorder, which means that people who inherit only one copy of
an identified risk allele will not develop clinical disease.
In addition to a clinical examination and family history, the diagnostic process for identifying patients with haemochromatosis should include measurement of ferritin
levels and transferrin saturation, which provide biochemical evidence of the patient’s iron metabolism. There are a number of possible causes of elevated ferritin other
than haemochromatosis, including acute illness and inflammation, alcohol intake, other liver conditions such as non-alcoholic steatohepatitis, hepatitis B and C, cancer,
excessive dietary intake of vitamin C or iron and iatrogenic elevations from blood or iron transfusions. Patients with elevated ferritin levels which cannot be
explained by these causes or those with transferrin saturation above 45% should undergo genetic testing for haemochromatosis. Genetic Health Services New Zealand
does not recommend genetic screening of asymptomatic family members unless it is performed following the recommendation of a clinician with relevant genetic
experience or after discussion with a genetic counsellor.
This audit focuses on key practice behaviours for the diagnosis and management of hereditary haemochromatosis:
- Patients being assessed for the possible diagnosis of haemochromatosis should have ferritin and transferrin saturation levels measured first
- Identify what proportion of these patients had evidence of elevated ferritin or transferrin saturation levels, or genetic advice, prior to genetic testing being ordered
- Genetic testing of asymptomatic family members of patients with haemochromatosis is only recommended following the advice of a genetic counsellor or clinician with genetic experience
The recommended steps for completing the audit are:
- Identify patients who have had genetic testing for haemochromatosis
- Patients with elevated ferritin levels that are not explained by other causes, or who have transferrin saturation levels greater than 45%, should undergo genetic testing for haemochromatosis
Consider what percentage of patients might be expected to meet the requirements above. Ideally this number will be 100%, however, 90% is suggested as a target standard.
For this audit patients who have had a haemochromatosis genetic test requested by you or another member of your practice should be identified from patient records.
This should be possible using the practice’s PMS system, e.g. practices that use Medtech can use the Query Builder tool to search the Inbox for terms such
as “haemochromatosis”, “HFE gene”, “C282Y” and “H63D”. Record the details of all patients who have had a genetic test for haemochromatosis
Ideally take all patients who have had a genetic test for haemochromatosis returned from a search, because based on the estimated prevalence
of hereditary haemochromatosis, the number in most practices should be relatively low. If your search returns large numbers of results, take the
first 20 patients. n the previous month to allow the sample size to reach 20.
Review patient notes
Review each patient’s notes to establish if there is a record of elevated ferritin or transferrin saturation levels or genetic advice obtained prior to genetic testing being ordered.
Criteria for a positive result
In order to score a positive result in this audit, patients who have had a genetic test for haemochromatosis should:
- Have had elevated ferritin or transferrin saturation prior to undergoing genetic testing if they were initially diagnosed by your practice
- Or have undergone family screening following the advice of a clinician with genetic experience or genetic counsellor
Identifying opportunities for Audit of Medical Practice
The first step to improving medical practice is to identify the criteria where gaps exist between expected and actual
performance and then to decide how to change practice.
Once a set of priorities for change have been decided on, an action plan should be developed to implement any changes.
It may be useful to consider the following points when developing a plan for action (RNZCGP 2002).
Problem solving process
- What is the problem or underlying problem(s).
- Change it to an aim.
- What are the solutions or options?
- What are the barriers?
- How can you overcome them?
Overcoming barriers to promote change
- Identifying barriers can provide a basis for change.
- What is achievable – find out what the external pressures on the practice are and discuss ways of dealing with them
in the practice setting
- Identify the barriers
- Develop a priority list
- Choose one or two achievable goals
- No single strategy or intervention is more effective than another, and sometimes a variety of methods are needed to
bring about lasting change
- Interventions should be directed at existing barriers or problems, knowledge, skills and attitudes, as well as performance
Monitoring change and progress
It is important to review the action plan at regular intervals. It may be helpful to review the following questions:
- Is the process working?
- Are the goals for improvement being achieved?
- Are the goals still appropriate?
- Do you need to develop new tools to achieve the goals you have set?
Following the completion of the first cycle, it is recommended that the doctor completes the first
part of the Audit
of Medical Practice summary sheet (Appendix 1).
Undertaking a second cycle
In addition to regular reviews of progress with the practice team, a second audit cycle should be completed in order to quantify progress on closing the gaps in performance.
It is recommended that the second cycle be completed within 12 months of completing the first cycle.
The second cycle should begin at the data collection stage. Following the completion of the second cycle it
is recommended that practices complete the remainder of the Audit
of Medical Practice summary sheet.
Claiming credits for Continuing Professional Development (CPD)
This audit has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for 10 CME credits for a first cycle and 10 CME credits for a second cycle for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes. The second cycle is optional and only two cycles are permissible.
To claim points go to the RNZCGP website: www.rnzcgp.org.nz
Record your completion of the audit on the CPD Online Dashboard, under the Audit of Medical Practice section.
From the drop down menu select “Approved practice/PHO audit” and record the audit name.
General practitioners are encouraged to discuss the outcomes of the audit with their peer group or practice.
As the RNZCGP frequently audit claims you should retain the following documentation, in order to provide adequate evidence of participation in this audit:
- A summary of the data collected
- An Audit of Medical Practice (CQI) Activity summary sheet (included as Appendix 1).